Evidence map›Paper›PMID 19955388›Full record

GuidelineSchizophrenia bulletin2010

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

Julie Kreyenbuhl, Robert W Buchanan, Faith B Dickerson, Lisa B Dixon, Schizophrenia Patient Outcomes Research Team (PORT)

Registry-linked trialAbstract readConsensus StatementPractice Guideline
In one paragraph

Guideline in Schizophrenia bulletin, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05500001 (Supporting Patients by Family Education in Psychotic Illness), which is not on this map. Cited by 171 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
171citing papers in PubMed, 11 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05500001 narecruitingnot on this mapstarted 2022, after this paper: background citation

Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study

TypeinterventionalSponsorUniversity of AlbertaRan2022 to 2026Enrolled113ConditionsPsychotic Disorders, Family Members, Anosognosia, ParanoiaArmsSupporting Patients by Family Education in Psychotic Illness Group
3 · Its place in the literature

Who cites it

171 citing papers in PubMed, 11 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Guideline
  11. Guideline
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

111 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Julie KreyenbuhlVA Capitol Health care Network (VISN 5) Mental Illness Research, Education, and Clinical Center, Baltimore, MD, USA. jkreyenb@psych.umaryland.edu
Robert W Buchanan
Faith B Dickerson
Lisa B Dixon
Schizophrenia Patient Outcomes Research Team (PORT)

Funding

Schizophrenia PORT Treatment Recommendations Update 2008R13MH080593 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI KREYENBUHL, JULIE A. · 2007 to 2008
$164k
NIMH NIH HHS R13 MH080593
6 · The paper itself

Abstract

The Schizophrenia Patient Outcomes Research Team (PORT) project has played a significant role in the development and dissemination of evidence-based practices for schizophrenia. In contrast to other clinical guidelines, the Schizophrenia PORT Treatment Recommendations, initially published in 1998 and first revised in 2003, are based primarily on empirical data. Over the last 5 years, research on psychopharmacologic and psychosocial treatments for schizophrenia has continued to evolve, warranting an update of the PORT recommendations. In consultation with expert advisors, 2 Evidence Review Groups (ERGs) identified 41 treatment areas for review and conducted electronic literature searches to identify all clinical studies published since the last PORT literature review. The ERGs also reviewed studies preceding 2002 in areas not covered by previous PORT reviews, including smoking cessation, substance abuse, and weight loss. The ERGs reviewed over 600 studies and synthesized the research evidence, producing recommendations for those treatments for which the evidence was sufficiently strong to merit recommendation status. For those treatments lacking empirical support, the ERGs produced parallel summary statements. An Expert Panel consisting of 39 schizophrenia researchers, clinicians, and consumers attended a conference in November 2008 in which consensus was reached on the state of the evidence for each of the treatment areas reviewed. The methods and outcomes of the update process are presented here and resulted in recommendations for 16 psychopharmacologic and 8 psychosocial treatments for schizophrenia. Another 13 psychopharmacologic and 4 psychosocial treatments had insufficient evidence to support a recommendation, representing significant unmet needs in important treatment domains.

Indexed as

Evidence-Based MedicineOutcome Assessment, Health CareSchizophrenic PsychologyAntipsychotic AgentsCombined Modality TherapyHumansPsychotherapyRandomized Controlled Trials as TopicSchizophreniaAntipsychotic Agents

Identifiers

PMID19955388
PMCPMC2800150

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.